Intellectual Property India Publishes Patent Application for Design, Synthesis And In-Vitro Evaluation Of Novel Fused Heterocyclics Derived 2-((4-Chlorophenyl)amino)thiazolo[4,5-D]pyrimidin-5(6h)- One Derivatives As Osteoblast Cell Inhibitors

MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202641055990 A) filed by G Buela Priyanka; Dr. M. Suchitra; Prathyusha Vuddanda; Pasumarthy Sree Mahalakshmi; Guttikonda Udaya; Pala Sasikala; and V. Shobha on May 02, 2026, for Design, Synthesis And In-Vitro Evaluation Of Novel Fused Heterocyclics Derived 2-((4-Chlorophenyl)amino)thiazolo[4,5-D]pyrimidin-5(6h)- One Derivatives As Osteoblast Cell Inhibitors.

Inventors include G Buela Priyanka; Dr. M. Suchitra; Prathyusha Vuddanda; Pasumarthy Sree Mahalakshmi; Guttikonda Udaya; Pala Sasikala; and V. Shobha.

The application for the patent was published on June 19, 2026, under issue no. 25/2026.

Abstract: Some novel compounds 2-((4-chlorophenyl)amino)t...